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Growing concern that phthalic acid esters
(PAE) may present a health hazard and pos-
sible deleterious effects on the ecological
system has led to increased interest in the
more subtle toxicity of those compounds.
Although the acute toxicity of PAEs as a
group is quite low, the intrinsic cellular
toxicity increases with molecular weight.
Whether the intrinsic toxicity is great
enough to exert a significant effect in vivo
at the typically low levels of solubility of
PAEs is of primary importance to the assess-
ment of their potential hazard. This paper
reviews work reported on the teratogenicity
of PAEs and new work on the mutagenicity,
cellular toxicity, and absorption, excretion,
and distribution of those compounds. The
relationship of in vitro and in vivo response
is discussed.
Teratogenicity
Teratogenicity of PAEs was examined by
Singh, Lawrence, and Autian (1). Six com-
pounds (dimethyl, dimethoxyethyl, diethyl,
dibutyl, diisobutyl, and butyl carbobutoxy-
methyl phthalate) were administered intra-
peritoneally to pregnant rats in doses of
one-tenth, one-fifth, and one-third of the
acute LD50 dose on the 5th, 10th and 15th
days of gestation. Dioctyl and di-2-ethylhexyl
phthalate had LD50 values of greater than
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50 ml/kg and were each administered at
dose levels of 5 and 10 ml/kg. The rats were
sacrificed on the 20th day of gestation, 1
day prior to expected parturation. The
uterine horns and ovaries were surgically ex-
posed to permit counting and recording of
the numbers of corpora lutea, resorption
sites, and viable dead fetuses. Fetal weights
were recorded, and the fetuses were exam-
ined for gross malformations. Thirty to fifty
per cent of the fetuses not showing gross
malformations were selected at random and
examined for skeletal malformations. The
regimen of PAE administration did not inter-
fere with fertility, as reflected by the ratio
of corpora lutea to implantation sites, but
there were significant effects upon embry-
onic and/or fetal development. Embryo-fetal
toxicity (dead fetuses plus resorption sites)
ranged from 0% for the middle dose of
diethyl phthalate to 98.2% for the high dose
of dimethoxyethyl phthalate. Fetal malfor-
mations ranged from 0% to 100%, both for
gross and skeletal abnormalities, with skel-
etal defects generally being more common.
Fetuses from all treated groups were signifi-
cantly smaller than fetuses of the control
group. Absence of tail, anophthalmia, and
twisted hind legs were most common gross
abnormalities, while elongated and fused ribs
and abnormal skull bones were the most
common skeletal deformities. The most em-
bryotoxic agent was dimethoxyethyl
phthalate, which was the most water-soluble
of the esters studied and the compound
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in tissue culture (discussed below). Dioctyl
and di-2-ethylhexyl phthalates tended to
have the least overall adverse effect on
embryo-fetal development and were the least
soluble of the compounds studied. All of the
PAEs studied showed a deleterious effect
upon the developing embryo and/or fetus.
At one or more of the dose levels employed,
some or all of the following effects were
observed for each compound: resorptions,
gross abnormalities, skeletal malformations,
fetal death, or decreased fetal size. The un-
treated control group showed no resorptions,
gross or skeletal abnormalities or fetal
deaths. Responses were generally dose-
related. Dimethoxyethyl phthalate was dis-
tinctly more teratogenic than the other
PAEs studied.
In the above cited study, the percentage
of skeletal abnormalities was generally cor-
related with the water solubilities of the
compounds. The percentages of gross ab-
normalities, however, were highest for the
most and the least water-soluble com-
pounds, dimethoxyethyl phthalate and di-
2-ethylhexyl phthalate, respectively. The
percentage of resorptions was highest for the
most soluble compound, dimethoxyethyl
phthalate, but showed relatively constant
percentage resorption (24.1-32.1%) for the
other compounds, diethyl and dioctyl
phthalate falling below that range. These re-
sults suggest that induction of skeletal
abnormalities may be dependent on non-
specific effects on bone formation related to
the absolute concentrations of the com-
pounds interacting with formative bone
interfaces, while gross abnormalities and re-
sorptions may reflect more specific inter-
actions related to both concentrations and
the intrinsic cellular toxicity of the com-
pounds. Dillingham, Chambers, and Autian
(2) have reported that the product of intrin-
sic toxicity in tissue culture (slope of the
dose-response curve) and the molar aqueous
solubility shows a constant ratio to the
acute LD50 in mice for a series of five
PAEs. The relative constancy of the percent
resorptions in the teratogenic study cited
above (1) may be related to the fact that
intrinsic cellular toxicity of PAEs increases
proportionally as water solubility decreases.
The bimodal distribution of gross abnormal-
ities probably reflects the specific nature and
relative ease of detection of gross deformity.
A degree of specificity or a disproportionate
increase in intrinsic toxicity with decreasing
solubility is suggested.
Mutagenicity
In view of the teratogenic potential of
PAEs the possible mutagenicity of those
compounds was investigated by Singh, Law-
rence, and Autian by dominant lethal assay
in mice (3). Their unpublished work is sum-
marized here.
Mutagenic effects of di-2-ethylhexyl
phthalate (DEHP) and dimethoxyethyl
phthalate (DMEP) were investigated by intra-
peritoneal administration of a single dose of
the respective undiluted esters to male (ICR)
mice immediately prior to the initiation of a
mating period in which 10 treated males
were mated (two females per male) each
week for 12 weeks. The results of that study
are summarized in Table 1. The dose levels
employed were one-third, one-half, and two-
thirds of the acute LD50 dose. A parallel
untreated mating group was maintained as a
control (240 matings). Shortly before ex-
pected parturation, the pregnant females
were sacrificed and the uterine horns ex-
posed surgically to permit recording of the
numbers of corpora lutea, total numbers of
implantations, preimplantation losses (by dif-
ference between those two parameters),
resorption sites (early fetal deaths), dead
fetuses (late fetal deaths), and viable fetuses.
Since there was a significant antifertility
effect with both compounds, only total
(early plus late) fetal deaths were employed
in the statistical test for dominant lethality.
The results reported are, therefore, a con-
servative estimate of dominant lethal effects
since some of the preimplantation losses
may have been due to dominant lethal muta-
tion. The significant reductions in mean live
fetuses per pregnancy and mean implants per
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Phthalate Dose, Pregnancies, Implantsa Fetal deathsa Live fetusesa
ester ml/kg % of control
None Untreated control 71 11.4 0.45 11.0
DEHP 12.78 56 11.3 0.80b 10.5
19.17 59 11.1 0.65c 10.5
25.56 22 10.5a 0-79b 9.6
DMEP 1.19 70 11.1 0.35 10.8
1.79 75 11.2 0.56 10.7
2.38 35 10.6b 0.74b 9.8
a Per pregnancy, mean values.
b Greater than 99% confidence (Student t test).
c Greater than 95% confidence (Student t test).
pregnancy at the high dose levels of both
compounds are consistent with the finding
of a significant level dominant lethal muta-
tion for both compounds. Mean implants per
pregnancy and mutagenic effects tended to
be bimodally distributed in the DEHP exper-
iment, significant differences from the con-
trol showing up during weeks 1-5 and
10-12. A similar distribution was observed
for mean implants per pregnancy in the
DMEP experiment; however, the mutagenic
effect was observed only at the high dose
level and distributed in the period between
weeks 2 and 9. The mutagenic effect of
DEHP was significantly greater than for
DMEP in contrast to the teratogenic effects
of those compounds.
Tissue Distribution, Dermal Absorption and Excretion
of PAE
Urinary excretion of 14C-DEHP by mice
receiving undiluted ester intraperitoneally
(IP) and saturated saline solution of the
ester intravenously (IV) was studied by
Dillingham and Pesh-Iman and reviewed by
Autian (2). The observed cumulative excre-
tion of the compound for the two experi-
ments is given in Figure 1. The IP dose was
5 ml/kg; the IV dose was lower by a factor
of 104. There was a very slight peak of
excretion at 24 hr following IV administra-
tion and a slightly higher cumulative excre-
tion compared to the cumulative excretion
following IP administration, but the pattern
of excretion was closely parallel for the two
routes.
A significant diuretic effect was observed
following IV administration of the DEHP
saturated saline solution and a distinct sup-
pression of urinary excretion following IP
administration of the undiluted ester. It was
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FIGURE 1. Cumulative urinary excretion of DEHP
by mice.
January 1973 83observed that the IV administration of
DEHP saturated saline to mice which had
been pretreated (a single IP dose of un-
diluted DEHP 3 days prior to IV administra-
tion, doses as in the above experiments) did
not lead to diuresis. The urinary output re-
mained at approximately the same level as in
the IP experiment.
The daily urinary excretion rates for the
above three experiments are given in Figure
2. Excretion showed a first-order decline fol-
lowing IV administration to both untreated
and IP-pretreated animals. There was a peak
of excretion at three days following IP
administration. In view of the relatively large
dose of DEHP administered IP (approximate-
ly 103 times the quantity required to satu-
rate the aqueous phase of a 25-g mouse,
based on water solubility) and in view of the
fact that only 23% of the administered dose
was excreted at the end of 3 days, a change
in the intrinsic rate of excretion after 3 days
was suggested or there may have been a
significant shift in the equilibrium between
the large PAE pool and the circulating fluid
compartment. To examine the question of
equilibrium between the circulating compart-
ment and the DEHP pool, the DEHP ad-
ministered in the above IP-IV experiment
was 14C-carboxyl-labeled. The daily excre-
tion rate, (Fig. 2) and the cumulative excre-
tion (Fig. 3) following IV administration of
the labeled compound was calculated on the
assumption that the IV administered labeled
ester reached rapid equilibrium with the un-
labeled DEHP pool (approximately 77% of
the IP administered dose, based on the data
of Figure 1; the excretion of unlabeled com-
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FIGURE 3. Urinary excretion of 14C-DEHP admin-
istered IV to mice on day 3 following IP injec-
tion of unlabeled DEHP.
pound was assumed to follow the same time
course as the labeled compound, and the
data of Fig. 1 are used in Fig. 3 for the IP
cumulative excretion of unlabeled com-
pound). The close agreement of the IV and
IP excretion curves (Fig. 3) is consistent
with the assumption of rapid equilibrium
and with the conclusion that the DEHP pool
at 3 days had not been metabolized to any
large degree. Approximately 83% of the
total administered dose (IP) was excreted by
14 days, and no significant radioactivity was
found in the urine of mice after 35 days.
The consistency of the excretion data based
on the assumption of free equilibrium be-
tween the circulating compartment and the
total residual pool suggested that a shift in
mechanism of excretion was involved rather
than time dependencies of transport. A small
amount of the radioactive compound was
found in the feces but not enough to ac-
count for any significant depletion of the
pool. The vapor pressure of the ester was
too low to assume any significant losses by
exhalation.
Dermal absorption of 14C-DEP (diethyl
phthalate, carboxyl-labeled) was determined
by application of the ester to the skin of
rabbits and assay of radioactivity in the
urine daily. Of the total applied radio-
activity, 9% was found in the urine at 24 hr,
14% at 48 hr, and 16-20% at 72 hr. A
similar experiment was carried out with
DEHP, except that radioactivity in organs
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below). Detectable radioactivity in several
tissues indicated absorption of DEHP
through the skin. A quantitative estimate of
the amount absorbed was not obtained.
The animals employed in each of the
above experiments were sacrificed at the end
of the experiment and organs and tissues
collected for determination of PAE distribu-
tion by assay of radioactivity. At 7 days
after IV administration of 14C-DEHP satu-
rated saline (Fig. 1), the highest specific
activity (dpm/g tissue) was found in the
lungs, lesser but significant amounts being
found in the brain, fat, heart, and blood,
with no apparent preferential deposition in
fatty tissue. Radioactivity observed in the
lung was significantly higher (by a factor of
10-20) than could be accounted for by
residual blood in the tissue. Fourteen days
following IP administration of 14C-DEHP
(Fig. 1), lungs showed the highest specific
activity relative to other organs and tissues,
although the absolute amount of radio-
activity was less than at 7 days. The distri-
bution of the total administered IP dose
found in organs and blood at 14 days was
0.34% in lung, 0.20% in brain, 0.18% in
heart, and 0.54% in blood. At 7 days follow-
ing IV administration, the distribution of
total administered dose in organs and tissues
was 1.15% in lungs, 0.11% in brain, 0.13%
in fat, 0.09% in heart, and 1.25% in blood.
Distribution 7 days following IV administra-
tion to IP-pretreated mice (Fig. 3) was very
similar.
Organs and tissues were collected from
rabbits after three days of dermal exposure
to 14C-DEHP. Radioactivity was detected by
radioautography of tissue sections of lung,
heart, liver, kidney, gonads and spleen. The
radioactivity was not random but showed
distinct intracellular localization. Skin and
subdermal fatty tissue at the site of applica-
tion showed no radioactivity, suggesting con-
siderable loss of radioactivity from tissues
during fixation (formalin). Radioactivity was
not uniformly distributed in all cells and,
where it was detected, appeared to be local-
ized in the nuclear region.
Cellular Toxicity of Dimethoxyethyl and Dimethyl
Phthalate
A study of the cellular toxicity of DMEP
and DMP (dimethyl phthalate) was carried
out by Wu, Dillingham, and Autian, Mate-
rials Science Toxicology Laboratories. That
work has been submitted for publication (4).
The following is a summary of the principal
findings.
The objective of the investigation was to
determine the intrinsic susceptability of
mammalian cells to the toxic effects of
DMEP and DMP in tissue culture. Growth
and protein synthesis were followed with
respect to cellular toxicity and observed in
vivo response.
Mouse fibroblast L-cells, NCTC clone 929
strain L (Earl), were employed in the investi-
gation. The cultures were maintained and
grown on Eable's medium to which appro-
priate concentrations of toxicant were
added. The per cent growth as compared to
the controls was calculated from protein
assay, an essentially linear relationship being
found between total protein and cell num-
ber. Two types of experiments were carried
out to determine the sensitivity of replicat-
ing and nonreplicating cells. The replicating
cell culture was established by inoculation
with 2 x 105 cells per assay tube. A parallel
experiment involving use of an inoculum of
2 x 106 cells per assay tube resulted in an
essentially nonreplicating culture (5). Dose re-
sponse was determined over 144 hr and 96
hr, respectively, for the two systems. Protein
turnover in the replicating system was deter-
mined by an experiment in which the cells
for inoculum were labeled by growing them
in the presence of 14C-L-leucine. The
labeled cells were added to unlabeled assay
medium, and the decline in specific activity
of protein was followed for 96 hr. The dif-
ference between the observed specific
activity and that expected from dilution by
newly synthesized unlabeled protein was
used to calculate the per cent turnover. The
above experiments were carried out with
DMEP. An experiment was also carried out
with dimethyl phthalate (DMP) in a replicat-
ing cell culture system by employing a ran-
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protein hydrolyzate). Label was added at
zero time, and the total radioactivity of the
cultures was followed in the untreated con-
trols and in cultures treated with 4.185 x
104M DMP over a period of 96 hr. One set
of DMP-treated cultures (unlabeled medium)
was pulse-labeled with 14C-Amino acids for
2 hr at 24-hr intervals.
The dose response obtained in the repli-
cating system (by protein assay) is shown in
Figure 4. Fourfold increase in cell numbers
was obtained in 72 hrs and fivefold increase
by 144 hr. There was a significant dose
response over the entire period with a
distinct increase in growth inhibition above
0.004M DMEP. The onset of significant
differential inhibition was between 24 and
48 hr. At the highest concentration of
DMEP, growth was completely inhibited
until after 72 hr, a decrease in cell numbers
(total protein) being apparent at 144 hr.
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In contrast to the replicating cell culture,
the nonreplicating cultures (Fig. 5) showed
essentially no response at the lower con-
centrations but showed a significant response
after 24 hr at 0.008M DMEP. The relative
insensitivity of replicating cells prior to the
first replication (24 hr) is apparent in the
experiment carried out with DMP (Fig. 6).
The radioactivity data of that experiment
closely followed total protein by independ-
ent protein assay for the continuous labeling
experiment, indicating an initial increase
(due to the first relatively uninhibited cell
division) followed by a decline in cell num-
ber which suggested active lysis of the cell
population after 24 hr. The rate of amino
acid uptake over the 96-hr period (pulse
labeling) was inversely related to the degree
of lysis (suppression of total protein). The
observed apparent increase in amino acid up-
take at 96 hr was probably due to decrease
in the unlabeled pool of L-leucine in the
144
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FIGURE 5. Growth inhibition
cells in the presence of DMEP.
DMP-C=4.185 x iO-4M dimethyl phthalate
continuous libeling
DMP-Pz4.185 x 10-4M dimethyl phtholata,
pulse labeling (2 tr.), dpm x 1O0
CONTROL= untreated, continuous labeling
of the data over the period of 48 to 96 hr
CONTRL was the approximately constant turnover ~002M values with decreasing concentration with re-
004M
spect to time, e.g., 0.O1M at 48 hr gave
31%, 0.008M at 72 hr gave 30%, and
0.006M at 96 hr gave 29%. Also, the 24-hr
turnover values along the same lines of com-
parison are approximately half those at 48
.008M hr, indicating a significantly lower rate of
turnover in the first 24 hr, a period of lower
sensitivity to the toxicant. The relative pro-
tein turnover with respect to time and con-
centration is given in Tables 3 and 4,
7'2 ,6 respectively. The significant difference of the
control is apparent as well as the significant
of nonreplicating difference in protein turnover in the first 24
hr as compared to later times. The relative
tumover remained approximately constant
with respect to time after 48 hr at each
concentration. There was, however, a de-
creasing effect on turnover with respect to
concentration. Since the doubling time for
NTt the L-cell was approximately 20-24 hr, the
degree of suppression of growth appears to
Table 2. Effect ofdimethoxyethyl phthalate on protein
turnover of L-cels.
DMEP concn, Protein turnover, %
mole/I. 24 hr 48 hr 72 hr 96 hr
0.000 1.8 6.2 11 18
0.002 4.7 8.8 15 17
0.004 4.4 14 15 24
0.006 5.5 18 22 29
0.008 7.8 22 30 40
0.010 8.2 31 46 57
HOURS
FIGURE 6. Growth inhibition of replicating cells in
the presence of DMP.
culture medium at the time of pulse label-
ing. The true rate of amino acid uptake was
increasingly less than the apparent values
with respect to time.
Protein turnover in the replicating culture
is given in Table 2. The turnover of cell
protein was a function of both age and
toxicant concentration. The salient feature
Table 3. Relationship ofprotein tumover at 96 hr to
turnover prior to 96 hr in a replicating cell culture
treated with DMEP.
DMEP concn, Ratio of protein turnover
mole/I. 96 hr/24 hr 96 hr/48 hr 96 hr/72 hr
0.0 10.0 2.9 1.6
0.002 3.6 1.9 1.1
0.004 5.5 1.7 1.6
0.006 5.3 1.6 1.3
0.008 5.1 1.8 1.3
0.010 7.0 1.8 1.2
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concentration to turnover at lower concentrations.
Ratio of turnover at indicated concentrations
Time, hr 0.01/0 0.01/0.002 0.01/0.004 0.01/0.006 0.01/0.008
24 4.5 1.7 1.9 1.5 1.1
48 5.0 3.5 2.2 1.7 1.4
72 4.2 3.1 3.1 2.1 1.5
96 3.2 3.4 2.4 2.0 1.4
be related to the number of cell divisions
and the concentration of the toxicant. This
relationship of toxicant effect and cell divi-
sion is consistent with the findings by
radioautography that systemically distributed
DEHP is localized in the nuclear region of
cells. Relatively few cells in any given tissue
section showed radioactivity by radioautog-
raphy, and this may be related to the rela-
tively low rate of cell division in somatic
tissue.
The distinct difference in susceptability of
replicating and nonreplicating cells and the
relationship of the toxic effect to cell divi-
sion provides some insight into the apparent
low toxicity of phthalate esters in vivo and
the manifest teratogenic (1) and mutagenic
activity of those compounds. In the terato-
genic study, the administration of phthalate
esters at a concentration of 1/3 of LD50
dose (the maximum dose administered) was
approximately the amount required to satu-
rate the aqueous compartment of the rat,
based on the water solubility of the com-
pound and assuming uniform and complete
distribution of the toxicant throughout the
body. The lowest administered dose in the
teratogenic study was approximately equiva-
lent to the highest administered dose in the
present in vitro study of DMEP. At that
dose level in the teratogenic study, 27.6%
embryo resorptions, 2.4% gross abnormal-
ities, and 92.9% skeletal abnormalities were
reported, with no apparent toxicity reported
for the pregnant female rats. The relative
insensitivity of nonreplicating cells to DMEP
in vitro is consistent with a finding of low in
vivo toxicity, assuming that the tissues of
the mature animal sustain a low maintenance
rate of cell division. However, embryonic
tissues do undergo extreme fluctuations in
cell division rates. At periods in development
of specific embryonic tissues where surges of
cell division is accompanied by increased
protein turnover, phthalate esters can pro-
duce a significant toxic response, assuming
the intrinsic susceptability of the cell to be
the same in vitro and in vivo.
These findings support the conclusion that
DMEP is highly toxic to tissues undergoing
significant rates of cell division and that the
teratogenic activity of DMEP may be the
result of heightened cell sensitivity associ-
ated with cell replication in embryonic
tissues. The low in vivo acute toxicity of
DMEP and, perhaps, of other phthalate
esters, may be related to the relatively low
maintenance rate of cell division and metab-
olism of somatic tissues as compared to
embryonic tissues. A similar mechanism of
action was suggested for DMP.
Mutagenicity of PAEs may also be related
to the phenomenon of heightened suscepta-
bility during periods of active cell division.
The postmeiotic period is a period of active
cell growth and maturation during sperma-
togenesis and may involve increased suscept-
ability to toxic (mutagenic) effects. Any
tissue which undergoes periodic surges of
cell division may be particularly liable to the
toxic effects of PAEs. It would be informa-
tive to investigate the effects of PAEs on
tissues (such as spleen, bone marrow, wound
tissue, and gonads) of mature animals where
cycles of stimulated cell division and
metabolic activity are encountered.
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